Jingdong Zhang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Prognostic Factors

Metastatic Colorectal Cancer

Top Venues

Cell death discovery

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yiming Ma, Ying Chen, Lei Zhan, Qian Dong, Yuanhe Wang, Xiaoyan Li, Lian He, Jingdong Zhang
CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signaling. Cell death discovery 10 (1) (2024)
Yiming Ma, Ying Chen, Lei Zhan, Qian Dong, Yuanhe Wang, Xiaoyan Li, Lian He, Jingdong Zhang
CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signaling. Cell death discovery 10 (1) (2024)
Yiming Ma, Ying Chen, Lei Zhan, Qian Dong, Yuanhe Wang, Xiaoyan Li, Lian He, Jingdong Zhang
CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signaling. Cell death discovery 10 (1) (2024)
Tian-Shu Liu, Yuxian Bai, Xiaoyan Lin, Wei Li, Jufeng Wang, Xiaochun Zhang, Hongming Pan, Chun-Mei Bai, Li Bai, Ying Cheng, Jingdong Zhang, Haijun Zhong, Yi Ba, Wenwei Hu, Rui-Hua Xu, Weijian Guo, Shukui Qin, Nong Yang, Jianwei Lu, Kohei Shitara, Ming Lei, Mingshun Li, Nicole Bao, Tian Chen, Lin Shen
First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis. International journal of cancer (2022)
Qian Dong, Yanwen Diao, Xin Sun, Yang Zhou, Jialing Ran, Jingdong Zhang
Evaluation of tyrosine kinase inhibitors combined with antiprogrammed cell death protein 1 antibody in tyrosine kinase inhibitor-responsive patients with microsatellite stable/proficient mismatch repair metastatic colorectal adenocarcinoma: protocol for open-label, single-arm trial. BMJ open 12 (4) (2022)
Yana Zhai, Weijun Bai, Jin Zhou, Qian Dong, Jingdong Zhang
Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases. BMC cancer 22 (1) (2022)
Lin Zhao, Longyang Jiang, Ming Zhang, Qiang Zhang, Qiutong Guan, Yalun Li, Miao He, Jingdong Zhang, Min-Jie Wei
NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay. Oncogene 40 (30) (2021)
Liuying Zhu, Yuanhe Wang, Yang Zhou, Qian Dong, Yun-Peng Liu, Jingdong Zhang
RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer. BioMed research international 2020 (2020)
Feifei Li, Lei Zhan, Qian Dong, Qiwei Wang, Yuanhe Wang, Xiaoyan Li, Yong Zhang, Jingdong Zhang
Tumor-Derived Exosome-Educated Hepatic Stellate Cells Regulate Lactate Metabolism of Hypoxic Colorectal Tumor Cells via the IL-6/STAT3 Pathway to Confer Drug Resistance. OncoTargets and therapy 13 (2020)
Zhuo Wang, Liqun Zhang, Jingyan Wang, Yuanhe Wang, Qian Dong, Haiyan Piao, Qiwei Wang, Jingdong Zhang
Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy. Journal of immunology research 2020 (2020)
Liqun Zhang, Jingdong Zhang, Yuanhe Wang, Qian Dong, Haiyan Piao, Qiwei Wang, Yang Zhou, Yang Ding
Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer. Journal of clinical laboratory analysis 33 (8) (2019)
Yanrong Li, Kai Wang, Na Song, Kezuo Hou, Xiaofang Che, Yang Zhou, Yunpeng Liu, Jingdong Zhang
Activation of IGF-1R pathway and NPM-ALK G1269A mutation confer resistance to crizotinib treatment in NPM-ALK positive lymphoma. Investigational new drugs 38 (3) (2019)
Ping Yu, Mingyi Zhou, Jinglei Qu, Lingyu Fu, Xuedan Li, Ruimei Cai, Bo Jin, Yuee Teng, Jing Liu, Jing Shi, Jingdong Zhang
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients. BMC cancer 18 (1) (2018)
Kai Wang, Yanrong Li, Na Song, Xiaofang Che, Kezuo Hou, Ling Xu, Ming Bai, Qiwei Wang, Yuanhe Wang, Yang Zhou, Meihui Cao, Yunpeng Liu, Jingdong Zhang
Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAFV600E mutation. Journal of cellular biochemistry 120 (4) (2018)